Molecular Human Reproduction, Vol. 7, No. 12, 1143-1149,
December 2001
© 2001 European Society of Human Reproduction and Embryology
Ovary and oogenesis |
Evidence of leptin expression in normal and polycystic human ovaries
1 Institute of Anatomy, University of Leipzig, Liebigstrasse 13, D-04103 Leipzig, 2 Department of Gynaecology and Obstetrics, St Georg Hospital, Eitingonstrasse 12, D-04105 Leipzig, Germany
| Abstract |
|---|
|
|
|---|
Leptin, the `obese' protein, is found in cultured granulosa cells derived from human pre-ovulatory follicles. However, the occurrence of leptin has not been studied in intact ovaries, either normal or polycystic, until now. Paraffin sections from 25 human ovaries of different cycle stages and 25 wedge resections of polycystic ovaries were investigated by means of immunochemistry. Additionally, three ovaries were available for reverse transcriptionpolymerase chain reaction analysis. Leptin-positive cells were located in the granulosa cells of pre-antral follicles, and distinctly in the thecal layer of intact and regressing antral follicles. In the corpus luteum (CL) in the developmental stage, the former epithelioid leptin-positive thecal cells became fibroblast-like in the septum. In the CL of the secretory stage, single leptin-positive cells were detected between luteal cells. In polycystic ovaries, leptin-positive cells were noted both in the hypertrophied thecal layer and in the luteinized granulosa layer. Our findings on leptin expression at the protein level were confirmed by a positive mRNA signal for leptin in granulosa cells and in the CL. Additionally, mRNA of the full-length leptin receptor OB-R and of the short isoforms B219.1B219.3 was identified in granulosa cells and the CL, as well as in the cortex and medulla. We conclude that leptin is produced in the ovary and may act in autocrine and paracrine ways.
human/leptin/leptin receptor/ovary/polycystic ovary
| Introduction |
|---|
|
|
|---|
Leptin, the obesity protein that is produced by the adipose tissue (Zhang et al., 1994
Leptin action in the ovary is conceivable, since the mRNAs for leptin and its receptors, both long and short isoforms (Glasow et al., 1998
; Kutoh et al., 1998
; Kitawaki et al., 2000
), have been detected in granulosa and cumulus cells of pre-ovulatory follicles from women undergoing IVF (Cioffi et al., 1997
). Furthermore, leptin immunofluorescence has been located in inner granulosa cells, and in non-fertilized and fertilized oocytes as well as in preimplantation stage embryos (Antczak and Van Blerkom, 1997
). Leptin suppresses steroidogenesis in granulosa cell cultures when co-stimulated by FSH and dexamethasone (Barkan et al., 1999
). Leptin also weakly inhibits gonadotrophin- and/or insulin-like growth factor (IGF)-I-induced steroidogenesis in bovine thecal and granulosa cells cultured for 2 days in serum-free medium (Spicer et al., 2000
). However, other findings have demonstrated leptin's stimulatory effect on aromatase activity and oestrogen production in luteinized granulosa cells from human pre-ovulatory follicles (Kitawaki et al., 1999
). With regard to the intact ovary, leptin receptor mRNA has been found in porcine (Lin et al., 2000
) and in human ovaries (Karlsson et al., 1997
), although the long and short receptor isoforms were not distinguished. However, there is still little or no information on leptin localization in the intact human ovary. For this reason, the objective of this study was to analyse leptin and its receptor expression both at the protein and mRNA levels during various stages of follicle growth and in a corpora lutea (CL).
| Materials and methods |
|---|
|
|
|---|
Tissues
The design of the study and sample numbers are presented in Table I
|
Immunohistology of normal ovaries as a retrospective study
A total of 21 women of reproductive age (1844 years) underwent oophorectomy for gynaecological diseases. The ovaries were fixed in 4% formaldehyde and embedded in paraffin wax at the Institute of Pathology, University of Leipzig. The timing of the patient's menstrual cycle was determined by the pathohistological report on the endometrium. All ovaries were serially sectioned. Each section of 7 µm thickness was mounted on object slides coated with paper glue (Cementit®; Merz und Benteli AG, Niederwangen, Switzerland) for section adherence. The first section of each series was stained with haematoxylin and eosin for histological classification of the ovarian cycle: (i) follicular phase (n = 7) when large antral follicles were present and CL regression was advanced; (ii) luteal phases (n = 14) according to the criteria of Corner and Clement (Corner, 1956
Immunohistology of polycystic ovaries as a retrospective study
Twenty-five small wedge resections of polycystic ovaries were reviewed at the Private Institute of Pathology, Ulm, Germany. The clinician had diagnosed PCOS and this was confirmed by the pathologist's diagnosis. Since detailed clinical information was missing, we refer only to polycystic ovaries.
Tissues for extraction of mRNA
Two ovaries with CL at the secretory stage and one with CL at the developmental stage were obtained from women aged 36, 41 and 56 years, having undergone oophorectomy for non-malignant gynaecological diseases (Department of Gynaecology and Obstetrics, St Georg Hospital, Leipzig, Germany). Written consent from the patients had been obtained. Samples of ovarian cortex and medulla, CL and abdominal adipose tissue as positive controls were snap-frozen in liquid nitrogen and stored at 80°C until use. Furthermore, granulosa cells from mature follicles were obtained from five patients undergoing IVF therapy (Centre of Reproductive Medicine, Leipzig, Germany). The experimental protocol and the use of the cells were submitted to the patients' written consent. Aspirates from different follicles of each patient were pooled and centrifuged in 45% isotonic Percoll® (Amersham Pharmacia Biotech, Freiburg, Germany) at 200xg for 5 min. The upper band was removed. Cells were washed three times (300xg for 3 min), and 1x105 cells/2 ml medium were seeded into a 6-well plate and cultured in complete Dulbecco's modified Eagle's medium (DMEM)/Ham's F12 (GIBCO BRL, Grand Island, NY, USA) with 15 mmol/l HEPES, 22 mmol/l NAHCO3 and 5% fetal calf serum for 3 days.
Indirect immunohistochemistry
We used the avidin-biotin-horseradish peroxidase (HRP) complex technique (Vectostain® Elite ABC kit; Vector Laboratories, Alexis, Grünberg, Germany) for immunohistochemistry. A polyclonal antibody against leptin 1:300, Ob (A-20) (Santa Cruz Biotechnology Inc., CA, USA) was used. For antibody dilution, phosphate-buffered saline (PBS), pH 7.4 with 0.25% bovine serum albumin (BSA; A-4378, Sigma, Deisenhofen, Germany) and for wash, buffer, 0.05 mol/l Tris-HCl-buffered saline (TBS, pH 7.6) were prepared. Staining was performed as described previously (Löffler et al., 2000
). Briefly, deparaffinized sections were pre-treated for antigen retrieval with 0.05% pronase E (type XIV; Sigma) in 0.5mol/l Tris-HCl, pH 7.6, at 37°C for 15 min. Endogenous peroxidase activity was quenched with 0.3% H2O2 in absolute methanol for 30 min. For reduction of the background staining, the sections were treated with 1.5% normal goat serum (Vector Laboratories) for 20 min. The samples were incubated with the primary antibody in a humid chamber at 4°C overnight. Negative controls were incubated with normal rabbit immunoglobulin fraction (20 g/l, DAKO, Hamburg, Germany) or with leptin-antibody which had been blocked by a blocking peptide (Santa Cruz Biotechnology). Oocytes known to be leptin-positive (Antczak and Van Blerkom, 1997
; Cioffi et al., 1997
) were considered as positive controls.
The next day, sections were incubated at room temperature for 30 min with the second goat-anti-rabbit antibody (BA-1000, Vector Laboratories), diluted 1:200 in TBS with 1.5% normal goat serum. After incubating the sections with the avidin-biotin-HRP complex, the reaction product was histochemically detected with 0.02% 3',3'-diaminobenzidine (DAB; Aldrich, Basel, Switzerland) in 0.05 mol/l Tris-HCl, pH 7.6, and with 0.03% H202. Sections were counter-stained with haematoxylin, dehydrated and mounted in Histokitt (Carl Roth GmbH, Karlsruhe, Germany).
By a similar method, leukocytes were located using a monoclonal antibody against the leukocyte common antigen (LCA; CD 45, DAKO) diluted 1:100. A goat-anti-mouse antibody (BA-9200, Vector Laboratories) diluted 1:200 was used as a secondary antibody, and the controls were incubated with mouse immunoglobulin G1(100 µg/ml, Dako).
Reverse transcriptionpolymerase chain reaction analysis
Total cellular RNA was isolated from different ovarian areas and granulosa cell cultures using the QIAGEN total RNA isolation kit (Qiagen GmbH, Hilden, Germany) according to the manufacturer's protocol. Genomic DNA was digested with 0.02 IU DNase/µg RNA (Roche Molecular Biochemicals, Mannheim, Germany) at 25°C for 10 min. Total RNA of 5 µg was taken to synthesize cDNA using a first-strand cDNA synthesis kit (Amersham Pharmacia Biotech) in a reaction volume of 15 µl.
Primer sequences and annealing temperatures for the simple reverse transcriptionpolymerase chain reaction (RTPCR) technique are shown in Table II
. The primer sequences for the long form of the OB-R have been published by Cioffi et al. and those for leptin and the short forms of the OB-R by Glasow et al. (Cioffi et al., 1997
; Glasow et al.., 1998
). Each 25 µl amplification reaction contained 2.5 µl 10x concentrated PCR buffer (15 mmol/l MgCl2), 0.3 IU Taq DNA polymerase (Roche Molecular Biochemicals), 100 µmol/l dNTPs (Perkin-Elmer, Weiterstadt, Germany), 0.1 µmol/l of each primer and 1 µl sample cDNA. Variations between the cDNA concentrations of different preparations were corrected by adjusting all cDNA samples to contain equal concentrations of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) cDNA, as described previously for a semi-quantitative competitive RTPCR (Aust et al., 1997
). The GAPDH competitor (1018 mol) was co-amplified with the sample cDNA in the same PCR tube and resolved by gel electrophoresis. The amount of cDNA used was that which gave an equal ratio between the sample cDNA signal and competitor signal intensity, thus equal amounts of cDNAs were used for each amplification. A PCR without sample cDNA served as a negative control, and mRNA from abdominal adipose tissue was used as a positive control.
|
| Results |
|---|
|
|
|---|
Leptin-positive cells in growing and regressing follicles and in the CL
Leptin-positivity occurred in the granulosa cells of pre-antral follicles (Figure 1A,B
|
|
|
Leptin-positive cells in polycystic ovarian follicles
Intact antral follicles were absent in polycystic ovaries. Follicular cysts developed with and without hypertrophy of the thecal layer. In addition, we found cysts with a luteinized thecal and granulosa layer. These follicular cysts with luteinization appeared to be the largest in diameter and their granulosa cells were distinctly larger in size than the thecal cells. Most follicular cysts displayed a moderate to strong leptin response (Table III
|
|
Leptin and leptin receptor mRNA in different ovarian regions and IVF granulosa cells
Leptin mRNA was detected in IVF granulosa cells and in the developing CL in high quantities, whereas lower quantities were found in the secretory CL (Figure 5
|
| Discussion |
|---|
|
|
|---|
This is the first report that shows leptin-positive cells which change in distribution and density in the intact human ovary. Leptin was located in the granulosa layer of pre-antral follicles. Yet in antral follicles, leptin was strongly expressed in the thecal layer, but seemed absent in the granulosa layer. However, one should interpret this finding with caution because our RTPCR analysis shows leptin mRNA in pre-ovulatory granulosa cells, and because others have detected leptin in pre-ovulatory granulosa cells and in cumulus cells (Cioffi et al., 1997
Leptin-positive cells display an epithelioid appearance in the thecal layer of antral follicles. The cells, which change to fibroblast-like cells in the CL in the early developmental stage, differ in morphology compared with LCA-positive leukocytes. In the secretory CL, the small-sized, leptin-positive cells are distributed in the septa and between luteal cells, often close to capillaries. The high number of leptin-positive luteal cells in the early CL and their decrease in the secretory stage was confirmed by the strong and moderate leptin mRNA signals respectively in developing and secretory CL. An accurate statement on different mRNA levels has not been obtained because of the simple RTPCR analysis used. The faint leptin mRNA signal observed in the cortex is likely to have been caused by oocytes in primordial and primary follicles, which may have been present in the PCR samples. No mRNA signal was found in the medulla, thus confirming the negative outcome for leptin staining by immunohistochemistry.
In PCOS, the initial recruitment and growth of follicles seems intact, yet the selection of the dominant follicle is disturbed and cysts develop (Erickson and Yen, 1993
). Some authors have reported higher serum leptin levels in women with PCOS than in those without PCOS (El Orabi et al., 1999
), but others contradict these findings for women at a given body mass index (Caro, 1997
; Gennarelli et al., 1998
). In this study, we have provided evidence of the conspicuous occurrence of leptin in the wall of polycystic follicles. This suggests that the local production of leptin is increased independently of the serum levels, which were probably high or normal in the 21 patients investigated. High local leptin concentrations may cause abnormalities in the FSH control system and in the synthesis of steroid hormones by granulosa cells, since hormonal dysregulations have been described for granulosa cells from polycystic follicles (Erickson et al., 1992
). Furthermore, a local excess of leptin production may interfere with the steroidogenic response induced by intra-ovarian factors e.g. IGF-I in the dominant follicle. A reduced oestrogen secretion signifies an inadequate signal for LH secretion and thus anovulation (Caprio et al., 2001).
This is the first report on the occurrence of transcripts for the long and short isoforms of the leptin receptor in various regions of the human ovary. The mRNA of both the long receptor and the short isoforms were found in granulosa cells and in the CL, cortex and medulla, where the receptors are expressed at varying intensities. However, we cannot exclude the possibility that the signal is caused by the presence of leukocytes, since both CD4+ and CD8+ T-lymphocytes express leptin receptors (Martin-Romero et al., 2000
). Mouse macrophages are also known to have functional leptin receptors (Lee et al., 1999
). The long form of leptin receptor mRNA has been detected in both thecal and granulosa cells isolated from ovaries of women with regular cycles (Agarwal et al., 1999
). Cultured granulosa cells display an inhibitory effect on steroidogenesis under the influence of leptin (Karlsson et al., 1997
; Barkan et al., 1999
), when otherwise they have augmented oestrogen production (Kitawaki et al., 1999
). It is thus likely that leptin is also involved in steroidogenesis in the intact ovary. The full-length leptin receptors in follicles, CL and the medulla may indicate a leptin-dependent autocrine and paracrine loop for steroid production and for any other as yet unknown peripheral leptin function.
| Acknowledgements |
|---|
|
|
|---|
The authors thank Dr F.A.Hmeidan (Centre for Reproductive Medicine, Goldschmidtstrasse 30, Leipzig) for aspirates from the patients undergoing IVF therapy and Dr R.Spanel (Institute of Pathology, Ulm, Germany) for the wedge resections of polycystic ovaries. This paper was supported by the Bundesministerium für Bildung und Forschung (BMBF) and the Interdisciplinary Centre of Clinical Research (IZKF) at the University of Leipzig (01KS9504/1), project B6.
| Notes |
|---|
3 To whom correspondence should be addressed. E-mail: Loeffler{at}medizin.uni-leipzig.de
| References |
|---|
|
|
|---|
Agarwal, S.K., Vogel, K., Weitsman, S.R. et al. (1999) Leptin antagonizes the insulin-like growth factor-I augmentation of steroidogenesis in granulosa and theca cells of the human ovary. J. Clin. Endocrinol. Metab., 84, 10721076.
Antczak, M. and Van Blerkom, J. (1997) Oocyte influences on early development: the regulatory proteins leptin and STAT3 are polarized in mouse and human oocytes and differentially distributed within the cells of the preimplantation stage embryo. Mol. Hum. Reprod., 3, 10671086.
Aust, G., Hofmann, A., Laue, S. et al. (1997) Human thyroid carcinoma cell lines and normal thyrocytes: expression and regulation of matrix metalloproteinase-1 and tissue matrix metalloproteinase inhibitor-1 messenger-RNA and protein. Thyroid, 7, 713724.[Web of Science][Medline]
Barkan, D., Jia, H., Dantes, A. et al. (1999) Leptin modulates the glucocorticoid-induced ovarian steroidogenesis.Endocrinology, 140, 17311738.
Bützow, T.L., Moilanen, J.M., Lehtovirta, M. et al. (1999) Serum and follicular fluid leptin during in vitro fertilisation: relationship among leptin increase, body fat mass, and reduced ovarian response. J. Clin. Endocrinol. Metab., 84, 31353139.
Caprio, M., Fabbrini, E., Isidori, A.M. et al. (2001) Leptin in reproduction. Trends Endocrinol. Metab., 12, 6572.[Web of Science][Medline]
Caro, J.F. (1997) Leptin is normal in PCOS, an editorial about three `negative' papers. J. Clin. Endocrinol. Metab., 82, 16851686.
Chehab, F.F., Lim, M.E. and Lu, R. (1996) Correction of the sterility defect in homozygous obese female mice by treatment with the human recombinant leptin. Nature Genet., 12, 318320.[Web of Science][Medline]
Cioffi, J.A., Van Blerkom, J., Antczak, M. et al. (1997) The expression of leptin and its receptors in pre-ovulatory human follicles. Mol. Hum. Reprod., 3, 467472.
Clement, P.B. (1987) Histology of the ovary. Am. J. Surg. Pathol., 11, 277303.[Web of Science][Medline]
Coleman, D.L. (1973) Effects of parabiosis of obese with diabetes and normal mice. Diabetologia, 9, 294298.[Web of Science][Medline]
Coleman, D.L. (1978) Obese and diabetes: two mutant genes causing diabetes-obesity syndromes in mice. Diabetologia, 14, 141148.[Web of Science][Medline]
Corner, W. (1956) The histological dating of the human CL of menstruation. Am. J. Anat., 98, 377401.[Web of Science][Medline]
El Orabi, H., Ghalia, A.A., Khalifa, A. et al. (1999) Serum leptin as an additional possible pathogenic factor in polycystic ovary syndrome. Clin. Biochem., 32, 7175.[Web of Science][Medline]
Erickson, G.F., Magoffin, D.A., Garzo, V.G. et al. (1992) Granulosa cells of polycystic ovaries: are they normal or abnormal? Hum. Reprod., 7, 293299.
Erickson, G.F. and Yen, S.C. (1993) The polycystic ovary syndrome. In Adashi, E.Y. and Leung, P.C.K. (eds) The Ovary. Raven Press Ltd, New York, pp. 561579.
Friedman, J.M. (1997) Leptin, leptin receptors and the control of body weight. Eur. J. Med. Res., 2, 713.[Medline]
Gennarelli, G., Holte, J., Wide, L. et al. (1998) Is there a role for leptin in the endocrine and metabolic aberrations of polycystic ovary syndrome? Hum. Reprod., 13, 535541.
Glasow, A., Haidan, A., Hilbers, U. et al. (1998) Expression of Ob receptor in normal human adrenals: differential regulation of adrenocortical and adrenomedullary function by leptin. J. Clin. Endocrinol. Metab., 83, 44594466.
Karlsson, C., Lindell, K., Svensson, E. et al. (1997) Expression of functional leptin receptors in the human ovary. J. Clin. Endocrinol. Metab., 82, 41444148.
Kitawaki, J., Kusuki, I., Koshiba, H. et al. (1999) Leptin directly stimulates aromatase activity in human luteinised granulosa cells. Mol. Hum. Reprod., 5, 708713.
Kitawaki, J., Koshiba, H., Ishihara, H. et al. (2000) Expression of leptin receptor in human endometrium and fluctuation during the menstrual cycle. J. Clin. Endocrinol. Metab., 85, 19461950.
Kutoh, E., Boss, O., Levasseur, F. et al. (1998) Quantification of the full length leptin receptor (OB-Rb) in human brown and white adipose tissue. Life Sci., 62, 445451.[Web of Science][Medline]
Lee, F.Y., Li, Y., Yang, E.K. et al. (1999) Phenotypic abnormalities in macrophages from leptin-deficient, obese mice. Am. J. Physiol., 276, C386C394.
Lin, J., Barb, C.R., Matteri, R.L. et al. (2000) Long form leptin receptor mRNA expression in the brain, pituitary, and other tissues in the pig. Domest. Anim. Endocrinol., 19, 5361.[Web of Science][Medline]
Löffler, S., Horn, L.C., Weber, W. et al. (2000) The transient disappearance of cytokeratin in human fetal and adult ovaries. Anat. Embryol., 201, 207215.[Medline]
Mantzoros, C.S., Cramer, D.W., Liberman, R.F. et al. (2000) Predictive value of serum and follicular fluid leptin concentrations during assisted reproductive cycles in normal women and in women with the polycystic ovarian syndrome. Hum. Reprod., 15, 539544.
Martin-Romero, C., Santos-Alvarez, J., Goberna, R. et al. (2000) Human leptin enhances activation and proliferation of human circulating T lymphocytes.Cell Immunol., 199, 1524.[Web of Science][Medline]
Spicer, L.J., Chamberlain, C.S. and Francisco, C.C. (2000) Ovarian action of leptin: effects on insulin-like growth factor-I-stimulated function of granulosa and thecal cells. Endocrine, 12, 5359.[Web of Science][Medline]
Trayhurn, P., Hoggard, N., Mercer, J.G. et al. (1999) Leptin: fundamental aspects. Int. J. Obes. Relat. Metab. Disord., 23 (Suppl. 1), 2228.
Zhang, Y., Proenca, R., Maffei, M. et al. (1994) Positional cloning of the mouse obese gene and its human homologue.Nature, 372, 425432.[Medline]
Submitted on May 29, 2001; accepted on September 19, 2001.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
M. Archanco, J. Gomez-Ambrosi, M. Tena-Sempere, G. Fruhbeck, and M. A. Burrell Expression of Leptin and Adiponectin in the Rat Oviduct J. Histochem. Cytochem., October 1, 2007; 55(10): 1027 - 1037. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Duerrschmidt, O. Zabirnyk, M. Nowicki, A. Ricken, F. A. Hmeidan, V. Blumenauer, J. Borlak, and K. Spanel-Borowski Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1-Mediated Autophagy in Human Granulosa Cells as an Alternative of Programmed Cell Death Endocrinology, August 1, 2006; 147(8): 3851 - 3860. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Munoz-Gutierrez, P A Findlay, C L Adam, G Wax, B K Campbell, N R Kendall, M Khalid, M Forsberg, and R J Scaramuzzi The ovarian expression of mRNAs for aromatase, IGF-I receptor, IGF-binding protein-2, -4 and -5, leptin and leptin receptor in cycling ewes after three days of leptin infusion Reproduction, December 1, 2005; 130(6): 869 - 881. [Abstract] [Full Text] [PDF] |
||||
![]() |
G Anifandis, E Koutselini, K Louridas, V Liakopoulos, K Leivaditis, T Mantzavinos, D Sioutopoulou, and N Vamvakopoulos Estradiol and leptin as conditional prognostic IVF markers Reproduction, April 1, 2005; 129(4): 531 - 534. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Craig, H. Zhu, P. W. Dyce, J. Petrik, and J. Li Leptin Enhances Oocyte Nuclear and Cytoplasmic Maturation via the Mitogen-Activated Protein Kinase Pathway Endocrinology, November 1, 2004; 145(11): 5355 - 5363. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Swain, R. L. Dunn, D. McConnell, J. Gonzalez-Martinez, and G. D. Smith Direct Effects of Leptin on Mouse Reproductive Function: Regulation of Follicular, Oocyte, and Embryo Development Biol Reprod, November 1, 2004; 71(5): 1446 - 1452. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Norman, M. Noakes, R. Wu, M. J. Davies, L. Moran, and J. X. Wang Improving reproductive performance in overweight/obese women with effective weight management Hum. Reprod. Update, May 1, 2004; 10(3): 267 - 280. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Archanco, F. J. Muruzabal, D. Llopiz, M. Garayoa, J. Gomez-Ambrosi, G. Fruhbeck, and M. A. Burrell Leptin Expression in the Rat Ovary Depends on Estrous Cycle J. Histochem. Cytochem., October 1, 2003; 51(10): 1269 - 1277. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||









